-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on HCA Healthcare, Lowers Price Target to $390

Benzinga·07/28/2025 13:51:37
Listen to the news
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $416 to $390.